Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
09/2004
09/10/2004WO2004075723A2 Methods for the early diagnosis of ovarian cancer
09/10/2004WO2004058799A3 Methods and compositions for inhibiting binding of ige to a high affinity receptor
09/10/2004WO2004044204A3 Variable fragments of single-chain camelide antibodies and uses thereof for diagnosing and treating various pathologies
09/10/2004WO2004041864A3 Passive hyperimmune antibody therapy in the treatment of anthrax
09/10/2004WO2004039841A3 Trimeric binding proteins for trimeric cytokines
09/10/2004WO2004029287A3 Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer
09/10/2004WO2004020579A3 Method of humanizing immune system molecules
09/10/2004WO2004019886A3 Methods for up-regulating antigen expression in tumors
09/10/2004WO2004009759A3 Novel proteins in enteroaggregative escherichia coli (eaec) useful for diagnosis and therapy of eaec infections
09/10/2004WO2004003019A3 Immunoglobin single variant antigen-binding domains and dual-specific constructs
09/10/2004WO2003104418A3 Reconstituted polypeptides
09/10/2004WO2003103532A3 Method for improving body weight gain and feed conversion efficiency in animals
09/10/2004WO2003076579A3 Cancer-linked gene as target for chemotherapy
09/10/2004WO2003045230A3 Novel compositions and methods for cancer
09/10/2004WO2002094780A3 Kinases and phosphatases
09/10/2004WO2002072141A9 Targeted ligands
09/10/2004CA2519193A1 Methods for the early diagnosis of ovarian cancer
09/10/2004CA2517074A1 Nucleic acid molecules, polypeptides, antibodies and compositions containing same useful for treating and detecting influenza virus infection
09/10/2004CA2517054A1 Use of nucleic acids encoding antibody-like molecules for use in medical treatment
09/10/2004CA2517037A1 Method for reducing levels of c-reactive protein
09/10/2004CA2516832A1 A molecule which binds cd80 and cd86
09/10/2004CA2516518A1 Antibody purification by protein a and ion exchange chromatography
09/10/2004CA2516378A1 Human antibodies specific for interleukin 15 (il-15)
09/10/2004CA2515453A1 Methods for preventing and treating tissue damage associated with ischemia-reperfusion injury
09/10/2004CA2515389A1 Monoclonal antibody and gene encoding the same, hybridoma, pharmaceutical compostion, and diagnostic reagent
09/10/2004CA2514329A1 Methods for the treatment of renal cell carcinoma
09/09/2004US20040177392 Crustaceans as production systems for therapeutic proteins
09/09/2004US20040176583 Non-B, non-C, non-G hepatitis virus gene, polynucleotide, polypeptide, virus particle, method for isolating virus particle, and method for detecting virus
09/09/2004US20040176577 Immunoassays for specific determination of SCCA isoforms
09/09/2004US20040176576 Antibodies against cancer
09/09/2004US20040176575 Compounds comprising modified secondary ligand binding site for treatment and prevention of infections, diabetes, emphysema, viral, endocrine and cell proliferative disorders
09/09/2004US20040176570 Intermediates and enzymes of the non-mevalonate isoprenoid pathway
09/09/2004US20040176298 Methods for identifying compounds for regulating muscle mass or function using vasoactive intestinal peptide receptors
09/09/2004US20040176285 Tip39 polypeptides
09/09/2004US20040176283 Methods and compositions for the design of synthetic vaccines
09/09/2004US20040176272 Uses of integrin alphavbeta3 antagonists
09/09/2004US20040175825 for drug screening/diagnostics for inflammation, arthritis and cancer; genetic engineering; kits
09/09/2004US20040175803 Interferon-alpha induced gene
09/09/2004US20040175791 DcR3 polypeptide, a TNFR homolog
09/09/2004US20040175789 for drug screening asthma, chronic obstructive pulmonary disease, emphysema, chronic bronchitis, acute respiratory distress syndrome, cough and acute bronchitis drugs; genetic engineering
09/09/2004US20040175787 for treating spastcity, trigeminal neuralgia, asthma, cough, emesis, ulcers, urinary incontinence and cocaine addiction
09/09/2004US20040175786 for the prevention of acute rejection reactions following organ transplantation; genetic engineering
09/09/2004US20040175766 Human pyrimidine receptor
09/09/2004US20040175758 Novel Goodpasture antigen-binding protein isoforms and protein misfolded-mediated disorders
09/09/2004US20040175755 Using apolipoprotein specific immunoglobulin to diagnosis and treat arteriosclerosis, hyperlipidemia and cardiovascular disorders
09/09/2004US20040175754 by determining the quantity of a post-translationally modified protein, other than phosphorylated tau, present in a body fluid; comprises determining the quantities of orthohydroxyhippuric acid; kits
09/09/2004US20040175743 Using cancer marker gene expression profile in peripheral blood mononuclear cells to diagnose cell proliferative disorders and screen efficacy of antitumor agents
09/09/2004US20040175738 Novel osteopontin derived chemotactic peptides and methods of use
09/09/2004US20040175736 Using nested oligonucleotide extension reaction to replicate preferential nucleotide sequences; gene expression analysis
09/09/2004US20040175730 Comprises nucleotide sequences coding polypeptide associated with vascular permeability or proliferation of endothelial cells for treating intestinal malabsorption syndrome
09/09/2004US20040175692 Chronic lymphocytic leukemia cell line
09/09/2004US20040175395 Contains connecting disulfide bridge; humanized monoclonal and polyclonal antibodies; diagnostic kits for respiratory syncytial virus
09/09/2004US20040175394 Prevention and treatment of amyloidogenic disease
09/09/2004US20040175385 Isolated antibody specifically binds to epitope specifically bound by antibody expressed by a clone; genetic engineering
09/09/2004US20040175384 Protein kinase C as a target for the treatment of respiratory syncytial virus
09/09/2004US20040175381 Inducing tolerance in primates
09/09/2004US20040175379 Erythropoietin receptor binding antibodies
09/09/2004US20040175378 Monoclonal antibody 3G4, or an antigen-binding region or immunoconjugate thereof, produced by hybridoma ATCC PTA 4545; binds to phosphatidyl serine
09/09/2004US20040175369 Stat3 antagonists and their use as vaccines against cancer
09/09/2004US20040175362 Infectivity-enhanced conditionally-replicative adenovirus and uses thereof
09/09/2004US20040175361 Modulator of desmosomal cadherin-mediated cell adhesion using a Trp(tryptophan)-containing cell adhesion recognition sequence; anticarcinogenic, antitumor, and antimetastasis agents
09/08/2004EP1454917A2 Diabody-type bispecific antibody
09/08/2004EP1454146A2 Compositions, kits, and methods for identification, assessment, prevention, and therapy of rheumatoid arthritis
09/08/2004EP1454142A2 Inhibition of tristetraproline for protection of the heart from cardiac injuries
09/08/2004EP1454141A1 Method for detecting allergies and use of an antibody to detect allergies
09/08/2004EP1454140A2 Diagnosis and treatment of atherosclerosis
09/08/2004EP1454138A2 Immunocytokines with modulated selectivity
09/08/2004EP1453963A2 A structure for presenting desired peptide sequences
09/08/2004EP1453952A2 Compositions and methods for normalizing assays
09/08/2004EP1453862A2 Novel immunoadhesins for treating and preventing toxicity and pathogen-mediated diseases
09/08/2004EP1453856A1 Beta-amyloid binding factors and inhibitors thereof
09/08/2004EP1453854A2 Human cdnas and proteins and uses thereof
09/08/2004EP1453608A2 Flexible processing apparatus for isolating and purifying viruses, soluble proteins and peptides from plant sources
09/08/2004EP1453540A2 Modulation of lir function to treat rheumatoid arthritis
09/08/2004EP1453383A2 A novel saitohin gene and uses of same
09/08/2004EP1017802B1 A potential effector for the grb7 family of signalling proteins
09/08/2004EP0792284B1 Novel polypeptides
09/08/2004CN1527944A In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells
09/08/2004CN1527880A Enhanced 2-keto-L-gulonic acid production
09/08/2004CN1527878A Shingolipid ceramide deacylase gene
09/08/2004CN1527840A Use of CD 25 binding molecules in steroid-resistant patients
09/08/2004CN1527839A Modified human brain-derived neutrophic factor (BDNF) with reduced immunogenicity
09/08/2004CN1527724A Liquid formulation comprising cetuximab and a fatty acid ester of polyoxyethylene sorbitan
09/08/2004CN1527723A Methods for treating or preventing skin disorders using CD2-binding agents
09/08/2004CN1526737A Molt-inhibiting hormone-1 protein of mitten crab
09/08/2004CN1526736A N-end fusion protein PC-1-e2 of human multicapsular protein-1
09/08/2004CN1526735A Immune globulin and its prepn and application
09/08/2004CN1526734A N-end monoclonal antibody MA7B1 of anti-human multicapsular protein-1
09/08/2004CN1526733A N-end polyclonal antibody PAPC1 of anti-human multicapsular protein-1
09/08/2004CN1165764C Anti PSMA antibody or antigen binding part, and their use
09/08/2004CN1165618C Polynucleotide immunogenic agents
09/08/2004CN1165548C Purification of human myocardial troponin I
09/08/2004CN1165344C Compsns. and methods for catalyzing hydrolysis of HIV gp120
09/08/2004CN1165342C Porcine reproductive and respiratory syndrome vaccine
09/08/2004CN1165303C DNA binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents
09/07/2004US6787646 Tumor suppressor molecules and methods of use
09/07/2004US6787644 Metalloprotease-disintegrin ADAM23 (SVPH3-17) nucleic acids
09/07/2004US6787643 Nucleic acid for use in kits for detection of preferential bacterial infection
09/07/2004US6787641 Identification of sel-12 and uses thereof
09/07/2004US6787638 Tumor specific human monoclonal antibodies and methods of use